Advanced search
Publication Cover
Epigenomics Volume 4, 2012 - Issue 6
Submit an article Journal homepage
241
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Epigenome-Wide Analysis in Familial Hypercholesterolemia Identified New Loci Associated with High-Density Lipoprotein Cholesterol Concentration

Simon-Pierre Guay1 Department of Biochemistry, Université de Sherbrooke, 225 St-Vallier Street, Chicoutimi, QC, G7H 7P2, Canada;2 ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC, CanadaView further author information
,
Gregory Voisin3 Genome Québec Innovation Centre, Montréal, QC, CanadaView further author information
,
Diane Brisson2 ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC, CanadaView further author information
,
Johannie Munger1 Department of Biochemistry, Université de Sherbrooke, 225 St-Vallier Street, Chicoutimi, QC, G7H 7P2, Canada;2 ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC, CanadaView further author information
,
Benoît Lamarche4 Institute of Nutraceuticals & Functional Foods, Université Laval, Québec, QC, CanadaView further author information
,
Daniel Gaudet2 ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC, Canada;5 Department of Medicine, Université de Montréal, Montréal, QC, CanadaView further author information
&
Luigi Bouchard1 Department of Biochemistry, Université de Sherbrooke, 225 St-Vallier Street, Chicoutimi, QC, G7H 7P2, Canada;2 ECOGENE-21 & Lipid Clinic, Chicoutimi Hospital, Saguenay, QC, CanadaCorrespondence[email protected]
View further author information
 show all
Pages 623-639 | Published online: 18 Dec 2012

References

  • Scanu AM , EdelsteinC. HDL: bridging past and present with a look at the future. FASEB J.22(12) , 4044–4054 (2008).
  • Genest JJ , McNamaraJR, SalemDN, SchaeferEJ. Prevalence of risk factors in men with premature coronary artery disease. Am. J. Cardiol.67(15) , 1185–1189 (1991).
  • Lamarche B , DespresJP, MoorjaniS, CantinB, DagenaisGR, LupienPJ. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis119(2) , 235–245 (1996).
  • Weber M , McNicollS, MarcilMet al. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Can. J. Cardiol. 13(3) , 253–260 (1997).
  • Sharrett AR , BallantyneCM, CoadySAet al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104(10) , 1108–1113 (2001).
  • Rader DJ , AlexanderET, WeibelGL, BillheimerJ, RothblatGH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res.50(Suppl.) , S189–S194 (2009).
  • Defesche J . World health organisation report on familial hypercholesterolemia. Atherosclerosis154(1) , 242 (2001).
  • Vohl MC , MoorjaniS, RoyMet al. Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec. Clin. Genet. 52(1) , 1–6 (1997).
  • Jansen AC , Van Aalst-Cohen ES, Tanck MW et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J. Intern. Med.256(6) , 482–490 (2004).
  • Jansen AC , Van Aalst-Cohen ES, Tanck MW et al. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol.25(7) , 1475–1481 (2005).
  • Pijlman AH , HuijgenR, VerhagenSNet al. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia. a large cross-sectional study in The Netherlands. Atherosclerosis 209(1) , 189–194 (2010).
  • Garcia CK , WilundK, ArcaMet al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292(5520) , 1394–1398 (2001).
  • Slimane MN , LestavelS, SunXet al. Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families. Atherosclerosis 154(3) , 557–565 (2001).
  • Briel M , Ferreira-GonzalezI, YouJJet al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 338 , b92 (2009).
  • Soutar AK , NaoumovaRP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med.4(4) , 214–225 (2007).
  • Hegele RA . Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. Atheroscler. Suppl.2(3) , 5–7 (2002).
  • Hogue JC , LamarcheB, GaudetDet al. Association of heterozygous familial hypercholesterolemia with smaller HDL particle size. Atherosclerosis 190(2) , 429–435 (2007).
  • Heller DA , De Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med.328(16) , 1150–1156 (1993).
  • Waterworth DM , RickettsSL, SongKet al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 30(11) , 2264–2276 (2010).
  • Van Aalst-Cohen ES , JansenAC, BoekholdtSMet al. Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia. Eur. J. Hum. Genet. 13(10) , 1137–1142 (2005).
  • Demirkan A , AminN, IsaacsAet al. Genetic architecture of circulating lipid levels. Eur. J. Hum. Genet. 19(7) , 813–819 (2011).
  • Weissglas-Volkov D , PajukantaP. Genetic causes of high and low serum HDL-cholesterol. J. Lipid Res.51(8) , 2032–2057 (2010).
  • Teslovich TM , MusunuruK, SmithAVet al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307) , 707–713 (2010).
  • Turcot V , BouchardL, FaucherGet al. DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity (Silver Spring) 19(2) , 388–395 (2011).
  • Van Der Graaf A , VissersMN, GaudetDet al. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring. Arterioscler. Thromb. Vasc. Biol. 30(12) , 2673–2677 (2010).
  • Talens RP , JukemaJW, TrompetSet al. Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. Int. J. Epidemiol. 41(1) , 106–115 (2012).
  • Cash HL , McGarveyST, HousemanEAet al. Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics 6(10) , 1257–1264 (2011).
  • Baccarelli A , WrightR, BollatiVet al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21(6) , 819–828 (2010).
  • Guay SP , BrissonD, MungerJ, LamarcheB, GaudetD, BouchardL. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics7(5) , 464–472 (2012).
  • Henikoff S , MatzkeMA. Exploring and explaining epigenetic effects. Trends Genet.13(8) , 293–295 (1997).
  • Bird A . DNA methylation patterns and epigenetic memory. Genes Dev.16(1) , 6–21 (2002).
  • Bouchard L , ThibaultS, GuaySPet al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 33(11) , 2436–2441 (2010).
  • Turner BM . Defining an epigenetic code. Nat. Cell Biol.9(1) , 2–6 (2007).
  • Sasaki H , IshiharaK, KatoR. Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J. Biochem.127(5) , 711–715 (2000).
  • Movassagh M , ChoyMK, GoddardM, BennettMR, DownTA, FooRS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One5(1) , e8564 (2010).
  • Gellersen B , KempfR. Human prolactin gene expression: positive correlation between site-specific methylation and gene activity in a set of human lymphoid cell lines. Mol. Endocrinol.4(12) , 1874–1886 (1990).
  • Gaudet D , ArsenaultS, BelangerCet al. Procedure to protect confidentiality of familial data in community genetics and genomic research. Clin. Genet. 55(4) , 259–264 (1999).
  • Gaudet D , VohlMC, JulienPet al. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians. Am. J. Cardiol. 82(3) , 299–305 (1998).
  • Alberti KG , ZimmetPZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med.15(7) , 539–553 (1998).
  • Lohman T , RocheA, MartorellR. Standardization of the Anthropometric Measurements. In: The Airlie (VA) Consensus Conference. Lohman T, Roche A, Martorel R (Eds). Human Kinetics, IL, USA 39–80 (1988).
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (ncep) Expert Panel On Detection, Evaluation, And Treatment Of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA285(19) , 2486–2497 (2001).
  • Alberti KG , ZimmetP, ShawJ. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med.23(5) , 469–480 (2006).
  • Grundy SM , CleemanJI, DanielsSRet al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17) , 2735–2752 (2005).
  • Kodach LL , JacobsRJ, VoorneveldPWet al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness‘ via the bone morphogenetic protein pathway. Gut 60(11) , 1544–1553 (2011).
  • Friedewald WT , LevyRI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem.18(6) , 499–502 (1972).
  • Bibikova M , BarnesB, TsanCet al. High density DNA methylation array with single CpG site resolution. Genomics 98(4) , 288–295 (2011).
  • Aydin A , ToliatMR, BahringS, BeckerC, NurnbergP. New universal primers facilitate pyrosequencing. Electrophoresis27(2) , 394–397 (2006).
  • Cartharius K , FrechK, GroteKet al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21(13) , 2933–2942 (2005).
  • Middelberg RP , FerreiraMA, HendersAKet al. Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. BMC Med. Genet. 12 , 123 (2011).
  • Ken-Dror G , TalmudPJ, HumphriesSE, DrenosF. APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men. Mol. Med.16(9–10) , 389–399 (2010).
  • Garenc C , VohlMC, BouchardC, PerusseL. LIPE C-60G influences the effects of physical activity on body fat and plasma lipid concentrations: the Quebec Family Study. Hum. Genomics3(2) , 157–168 (2009).
  • Hozoji-Inada M , MunehiraY, NagaoK, KiokaN, UedaK. Liver X receptor β (LXRβ) interacts directly with ATP-binding cassette A1 (ABCA1) to promote high density lipoprotein formation during acute cholesterol accumulation. J. Biol Chem.286(22) , 20117–20124 (2011).
  • Lowe XR , LuX, MarchettiF, WyrobekAJ. The expression of Troponin T1 gene is induced by ketamine in adult mouse brain. Brain Res.1174 , 7–17 (2007).
  • Yoshida T , YajimaK, HibinoTet al. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. Int. J. Mol. Med. 20(4) , 581–590 (2007).
  • Wang Y , LukAO, MaRCet al. Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and β-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 diabetes – an 8-year prospective cohort analysis of 1297 patients. Diabet. Med. 27(4) , 376–383 (2010).
  • Clement K , VaisseC, ManningBSet al. Genetic variation in the β 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333(6) , 352–354 (1995).
  • Hla T , NeilsonK. Human cyclooxygenase-2 cDNA. Proc. Natl Acad. Sci. USA89(16) , 7384–7388 (1992).
  • Li W , XuJ, WangXet al. Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: a meta-analysis. Atherosclerosis 207(2) , 492–495 (2009).
  • Lee CR , NorthKE, BrayMS, CouperDJ, HeissG, ZeldinDC. Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Clin. Pharmacol. Ther.83(1) , 52–60 (2008).
  • Wang D , ChenQ, ZhangC, RenF, LiT. DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis. Eur. J. Med. Res.17(1) , 12 (2012).
  • Ma J , DempseyAA, StamatiouD, MarshallKW, LiewCC. Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. Atherosclerosis191(1) , 63–72 (2007).
  • Novelli G , GennarelliM, RocchiM, DallapiccolaB. Assignment of the slow troponin T (TNNT1) gene to chromosome 19 using polymerase chain reaction. Hum. Genet.88(6) , 697–698 (1992).
  • Kischel P , BastideB, MullerMet al. Expression and functional properties of four slow skeletal troponin T isoforms in rat muscles. Am. J. Physiol. Cell Physiol. 289(2) , C437–C443 (2005).
  • Manuylov NL , TevosianSG. Cardiac expression of Tnnt1 requires the GATA4-FOG2 transcription complex. Sci. World J.9 , 575–587 (2009).
  • Yanai I , BenjaminH, ShmoishMet al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21(5) , 650–659 (2005).
  • Zhang W , PatilS, ChauhanBet al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281(15) , 10105–10117 (2006).
  • Kim MS , PakYK, JangPGet al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 9(7) , 901–906 (2006).
  • Wu W , ChaudhuriS, BrickleyDR, PangD, KarrisonT, ConzenSD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res.64(5) , 1757–1764 (2004).
  • Dempster EL , PidsleyR, SchalkwykLCet al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20(24) , 4786–4796 (2011).
  • Bell CG , TeschendorffAE, RakyanVK, MaxwellAP, BeckS, SavageDA. Genome-wide DNA methylation analysis for diabetic nephropathy in Type 1 diabetes mellitus. BMC Med. Genomics3 , 33 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.